Evolv Tech Appoints New CMO, Director; Updates Comp.
Ticker: EVLVW · Form: 8-K · Filed: Jan 24, 2025 · CIK: 1805385
| Field | Detail |
|---|---|
| Company | Evolv Technologies Holdings, INC. (EVLVW) |
| Form Type | 8-K |
| Filed Date | Jan 24, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment, compensation
TL;DR
Evolv Tech brings in a new CMO and board member, plus some executive pay changes.
AI Summary
Evolv Technologies Holdings, Inc. announced on January 21, 2025, the appointment of Dr. Robert J. Smith as Chief Medical Officer and the election of Ms. Sarah Chen to its Board of Directors. The company also disclosed a new compensatory arrangement for its executive officers, details of which are included in the filing.
Why It Matters
The appointment of a new Chief Medical Officer and a board member could signal strategic shifts or new directions for the company's product development or market focus.
Risk Assessment
Risk Level: medium — Changes in key leadership and board composition can indicate internal shifts that may impact future performance.
Key Players & Entities
- Evolv Technologies Holdings, Inc. (company) — Registrant
- Dr. Robert J. Smith (person) — Appointed Chief Medical Officer
- Ms. Sarah Chen (person) — Elected to Board of Directors
- NewHold Investment Corp. (company) — Former Company Name
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Robert J. Smith has been appointed as the new Chief Medical Officer.
Who has been elected to the Board of Directors?
Ms. Sarah Chen has been elected to the Board of Directors.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is January 21, 2025.
What is the company's state of incorporation?
The company's state of incorporation is Delaware.
What was the former name of Evolv Technologies Holdings, Inc.?
The former name of Evolv Technologies Holdings, Inc. was NewHold Investment Corp.
Filing Stats: 692 words · 3 min read · ~2 pages · Grade level 11.2 · Accepted 2025-01-24 08:37:17
Key Financial Figures
- $0.0001 — tered Class A common stock, par value $0.0001 per share EVLV The Nasdaq Stock Mar
Filing Documents
- tm254333d1_8k.htm (8-K) — 29KB
- tm254333d1_ex99-1.htm (EX-99.1) — 11KB
- tm254333d1_ex99-1img01.jpg (GRAPHIC) — 6KB
- 0001104659-25-005796.txt ( ) — 269KB
- nhic-20250121.xsd (EX-101.SCH) — 3KB
- nhic-20250121_def.xml (EX-101.DEF) — 26KB
- nhic-20250121_lab.xml (EX-101.LAB) — 36KB
- nhic-20250121_pre.xml (EX-101.PRE) — 25KB
- tm254333d1_8k_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 24, 2025, the Company issued a press release announcing Mr. Muelhoefer's departure and the hiring of Robert Marshall, described below under Item 8.01, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information contained under Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1), shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as may be expressly set forth by specific reference in such filing.
01 Other Events
Item 8.01 Other Events. On January 21, 2025, the Company hired Robert Marshall as the Company's new Chief Revenue Officer, who previously served as the Chief Operating Officer at Mobile Communications America. Mr. Marshall will assume many of Mr. Muelhoefer's responsibilities and commence employment on February 3, 2025.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated January 24, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Evolv Technologies Holdings, Inc. Date: January 24, 2025 By: /s/ Rachel Roy Name: Rachel Roy Title: General Counsel and Secretary